JNK Kinase regulates cachexia like syndrome in scribble knockdown tumor model of Drosophila melanogaster

Rohit Kumar1, S Srikrishna1

  • 1Banaras Hindu University, India.

Developmental Biology
|September 18, 2024
PubMed

Insights

Cancer-associated cachexia involves organ wasting. Blocking JNK signaling in flies with a scribble gene mutation rescued lethality and organ wasting, suggesting a therapeutic target for cancer cachexia.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Genetics

Background:

  • Cachexia and systemic organ wasting are metabolic syndromes frequently linked to cancer, but their precise mechanisms remain unclear.
  • Scribble (scrib), a cell polarity regulator and tumor suppressor, is often lost or mis-localized in various cancers, including breast, colon, and prostate cancer.

Purpose of the Study:

  • To investigate the role of JNK kinase in cancer-associated cachexia-like syndrome using a fly model.
  • To explore the potential of targeting JNK signaling as a therapeutic strategy for cachexia.

Main Methods:

  • Utilized a Drosophila melanogaster model with induced hindgut tumors via scribble (scrib) knockdown.
  • Assessed male lethality, lifespan, systemic organ wasting, and phosphorylated JNK (pJNK) levels.
  • Investigated the effect of knocking down the JNK kinase analogue, hep, in the scrib knockdown background.

Main Results:

  • Scrib knockdown in flies induced male lethality, reduced lifespan, systemic organ wasting, and increased pJNK levels in the hindgut.
  • Knocking down hep in the scrib knockdown background restored normal lifespan and reduced organ wasting, indicating JNK pathway involvement.
  • Scrib loss in the hindgut was shown to induce a cachexia-like syndrome, including gut barrier disruption.

Conclusions:

  • The study demonstrates that scribble loss in the hindgut can trigger cancer-associated cachexia-like syndrome.
  • Blocking the JNK signaling pathway effectively rescued cachexia and gut barrier disruption induced by scrib knockdown.
  • These findings offer new insights into cancer cachexia mechanisms and suggest JNK signaling as a potential therapeutic target.